The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?
Abstract
A controversy has arisen over the past several years about the true origin of the human MDA-MB-435 cell line. Originally described as a human breast cancer cell line, subsequent expression array studies instead suggested a gene expression profile consistent with a melanoma origin. Subsequent karyotype and comparative genomic hybridization studies supported the idea that current stocks of both MDA-MB-435 cells and M14 melanoma cells must be identical cell lines, and the conclusion was drawn that both cell lines were in fact M14 melanoma cells. However, an alternate conclusion based on these data is that both cell lines are indeed identical, but are in fact MDA-MB-435 breast cancer cells. There is evidence that many cell lines can display “lineage infidelity” and that assignment to tissue type is unreliably made based on expression patterns. Evidence from the literature is presented here that is inconsistent with both lines being of M14 melanoma origin, but rather is consistent with both cell lines being of MDA-MB-435 breast cancer origin. [Cancer Res 2009;69(13):5292–3]
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Having already observed that three X‐specific SNP loci were also hemi‐ or homozygous, we concluded that the most likely mechanism for the observed XX karyotype was X‐chromosomal uniparental disomy, with the two X chromosomes having arisen by chromosomal duplication.34”
From Authentication of M14 melanoma cell line proves misidentification of MDA‐MB‐435 breast cancer cell line (2018) · cites this paper as [12]
In the citing paper
“we then investigated the previously reported XX karyotype12, 15”
From Authentication of M14 melanoma cell line proves misidentification of MDA‐MB‐435 breast cancer cell line (2018) · cites this paper as [12]
In the citing paper
“Analysis of LOX and LOXL1-4 expression in breast cancer cell lines revealed that hypoxia induced LOX and LOXL4 expression in MDA-MB-231 cells, whereas LOXL2 was induced in MDAMB-435 BCCs [56], and expression of LOX/LOXL proteins was not detected in non-metastatic MCF-7 BCCs [53].”
From The hypoxic tumor microenvironment: A driving force for breast cancer progression (2016) · cites this paper as [56]
Citations
Cites
Systematic variation in gene expression patterns in human cancer cell lines
Ross, D. T., Scherf, U., Eisen, M. B., Perou, C. M., Rees, C., Spellman, P., Iyer, V., Jeffrey, S. S., Van de Rijn, M., Waltham, M., et al. (2000) · Nature Genetics · doi:10.1038/73432 · Cited by 2,088 · cited 3×
“In addition to the expression array study by Ross and colleagues (6), Sellappan and colleagues have reported that these cells express melanocyte”
BackgroundInfluentialX chromosomal abnormalities in basal-like human breast cancer
Richardson, A. L., Wang, Z. C., De Nicolo, A., Lu, X., Brown, M., Miron, A., Liao, X., Iglehart, J. D., Livingston, D. M., & Ganesan, S. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.013 · Cited by 869 · cited 1×
“also been reported to occur in breast cancer (22, 23).”
BackgroundLong-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization
Cailleau, R., Olivé, M., & Cruciger, Q. V. J. (1978) · In Vitro · doi:10.1007/bf02616120 · Cited by 679 · cited 1×
“The MDA-MB-435 cell line was derived in the late 1970s from the pleural effusion of a female patient with breast cancer (1), and has”
(1990) · PubMed · Cited by 612
Rae, J. M., Creighton, C. J., Meck, J. M., Haddad, B. R., & Johnson, M. D. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9392-8 · Cited by 374 · cited 3×
“inconsistent with the karyotype results reported years later, which indicate that currently available stocks of M14 cells are of female origin (5, 18).”
BackgroundResultTechnical considerations for studying cancer metastasis in vivo
Welch, D. R. (1997) · Clinical & Experimental Metastasis · doi:10.1023/a:1018477516367 · Cited by 194
Tuna, M., Knuutila, S., & Mills, G. B. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.01.005 · Cited by 177 · cited 1×
“also been reported to occur in breast cancer (22, 23).”
BackgroundMetastasis from human breast cancer cell lines
Price, J. E. (1996) · Breast Cancer Research and Treatment · doi:10.1007/bf01806081 · Cited by 174
Further evidence to support the melanocytic origin of MDA-MB-435
Ellison, G. (2002) · Molecular Pathology · doi:10.1136/mp.55.5.294 · Cited by 164
Lineage Infidelity of MDA-MB-435 Cells
Sellappan, S., Grijalva, R., Zhou, X., Yang, W., Eli, M. B., Mills, G. B., & Yu, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-3299-2 · Cited by 163 · cited 2×
“proteins such as tyrosinase and melan A (9).”
Background
Cited by
Barry-Hamilton, V., Spangler, R., Marshall, D., McCauley, S., Rodriguez, H. M., Oyasu, M., Mikels, A., Vaysberg, M., Ghermazien, H., Wai, C., et al. (2010) · Nature Medicine · doi:10.1038/nm.2208 · Cited by 870
“Although our analysis of different xenograft tumor models typically revealed a comparatively poor desmoplastic response, we identified the aggressive breast cancer cell line MDA-MB-435 (ref”
BackgroundChavez, K. J., Garimella, S. V., & Lipkowitz, S. (2011) · Breast Disease · doi:10.3233/bd-2010-0307 · Cited by 762
“However, the M14 cell line was derived from a 33 year old male with melanoma at UCLA while all of the existing clones of the MDA-MB-435 and M14 cell lines are female [30, 31].”
BackgroundSynthesis of site-specific antibody-drug conjugates using unnatural amino acids
Axup, J. Y., Bajjuri, K. M., Ritland, M., Hutchins, B. M., Kim, C. H., Kazane, S. A., Halder, R., Forsyth, J. S., Santidrian, A. F., Stafin, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211023109 · Cited by 596
The hypoxic tumor microenvironment: A driving force for breast cancer progression
Semenza, G. L. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.05.036 · Cited by 535
“Analysis of LOX and LOXL1-4 expression in breast cancer cell lines revealed that hypoxia induced LOX and LOXL4 expression in MDA-MB-231 cells, whereas LOXL2 was induced in MDAMB-435 BCCs [56], and expression of LOX/LOXL proteins was not detected in non-metastatic MCF-7 BCCs [53].”
BackgroundLu, X., Mu, E., Wei, Y., Riethdorf, S., Yang, Q., Yuan, M., Yan, J., Hua, Y., Tiede, B. J., Lu, X., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.11.002 · Cited by 492
“Finally, MDA-MB-435, coexpressing both epithelial and melanocytic markers (Chambers, 2009), contains discernable level of VCAM-1 (Figure 3G) and displays mild aggressiveness tobone (Lu et al.”
Metadata
- Authors
- Chambers, A. F.
- Affiliations
- Western University (CA)
- Corresponding author
- Chambers, Ann F.
- ORCID
- Chambers, Ann F.
- Venue
- Cancer Research
- Published
- 2009-07-01
- Volume
- 69
- Issue
- 13
- Pages
- 5292-5293
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W1992324708
- Cited by
- 218
- References
- 25
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 6 · 2022: 1 · 2021: 4 · 2020: 2 · 2019: 3 · 2018: 7 · 2017: 10 · 2016: 9 · 2015: 17 · 2014: 16 · 2013: 25 · 2012: 24
- FWCI
- 18.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- cell line origin, lineage infidelity, gene expression profiling, karyotype, comparative genomic hybridization, breast cancer cell lines, melanoma cell lines, cell line misidentification
- MeSH terms
- Breast Neoplasms, Cell Differentiation, Female, Genetic Markers, Histocompatibility Testing, Humans, Lactation, Melanoma, Milk, Human, DNA, Complementary, Oligonucleotide Array Sequence Analysis, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma? https://app.cochat.ai/papers/10.1158/0008-5472.can-09-1528
- The paper
- Chambers, A. F. (2009). MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma? Cancer Research. https://doi.org/10.1158/0008-5472.can-09-1528
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.